SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000812796-09-000002
Filing Date
2009-01-16
Accepted
2009-01-16 15:01:36
Documents
2
Period of Report
2009-01-12
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CHANGE IN AUDITORS dor8kchangeauditors.htm 8-K 29725
2 LETTER TO SEC TO EFFECT CHANGE sweeneysecletter.htm EX-16.1 6424
  Complete submission text file 0000812796-09-000002.txt   37873
Mailing Address 850 BEAR TAVERN ROAD SUITE 201 EWING NJ 08628
Business Address 850 BEAR TAVERN ROAD SUITE 201 EWING NJ 08628 609-538-8200
DOR BIOPHARMA INC (Filer) CIK: 0000812796 (see all company filings)

IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-16929 | Film No.: 09531198
SIC: 2834 Pharmaceutical Preparations